Learn how beta measures stock volatility and its role in risk assessment, helping you make informed investment decisions.

IRVINE, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial ...

The consensus estimate for Q1 2026 revenue is $26.97 million, and the earnings are expected to come in at -$0.50 per share. The full year 2026's revenue is expected to be $132.59 million, and the ...

January 1, 2025, marks the beginning of Generation Beta. 58% of current and prospective parents believe Generation Beta may never retire. The next correction is closer than you think. Find out how Tom ...

BETA Technologies, Inc. (NYSE: BETA) ("BETA" or "the Company"), an electric aerospace company, today announced it will ...

Net sales of $23.2 million, up 54% compared to $15.0 million in the second quarter of 2024. Durable Medical Equipment (DME) channel net sales of $18.6 million, up 31% compared to $14.3 million in the ...

Beta Bionics, Inc., a leader in diabetes management solutions, announced it will release its first quarter financial results for 2025 on May 6, 2025, after market close. Management will hold a ...

Smart beta strategy blends passive and active investing, focusing on volatility, quality, and value factors. Learn how it ...

Beta Bionics, Inc. has announced that it will release its financial results for the second quarter of 2025 after the markets close on July 29, 2025. Following the release, company management will host ...